Prenatal Exercise and Glucose Regulation
University of Central Arkansas · NCT07802262
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–35 · Women only
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 23
- US sites recruiting
- 1
- Study start
- September 24, 2024
- Record last updated
- September 3, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
Gestational diabetes mellitus (GDM) is the most common disease during pregnancy and is characterized by an inability to regulate blood glucose (sugar) levels because of resistance to the hormone, insulin, which is responsible for getting glucose out of the blood. Aerobic training (AT, "cardio," for example: walking) is commonly used to regulate blood glucose levels in similar populations, like diabetics, but another form of exercise known as resistance training (RT, for example: weightlifting), has shown to be just as effective. Further, exercise intensity, regardless of the type, is directly proportional to blood glucose control. However, no study has compared AT and RT exercise modalities or intensity on blood glucose regulation in GDM, even though women with GDM share a similar insulin resistant phenotype as diabetics. Therefore, long-term objective of this study is to compare the effects of exercise type and intensity on glucose regulation and insulin sensitivity after four acute exercise sessions: low intensity RT (LOW-RT), low intensity AT (LOW-AT), moderate intensity RT (MOD-RT), moderate intensity AT (MOD-AT). Researchers will address the following aims:
Specific Aim 1: Determine the impact of exercise type and intensity on glucose regulation using continuous glucose monitoring during- and for 24 hours after four acute exercise sessions: LOW-RT, LOW-AT, MODRT, and MOD-AT. Researchers hypothesize that RT and moderate intensity will elicit better glucose control compared to AT and low intensity, respectively.
Specific Aim 2: Determine the impact of exercise type and intensity on insulin sensitivity by quantifying the quantitative insulin-sensitivity check index (QUICKI) before and after four acute exercise sessions: LOWRT, LOW-AT, MOD-RT, and MOD-AT. Researchers hypothesize that RT and moderate intensity will elicit greater insulin sensitivity compared to AT and low intensity, respectively.
Being studied: Acute exercises sessions with different exercise types and intensities
Conditions: Gestational Diabetes Mellitus; Gestational Diabetes Mellitus in Pregnancy; Insulin Resistance
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Biological female
- Singleton (one fetus)
- 24-30-wks gestation
- 18-35 yrs old
- Sedentary
- Conception without the use of assisted fertility treatments
Exclusion Criteria
- Existing other metabolic disorders
- Currently taking medication or supplements that affect glucose metabolism
- Taking drugs, tobacco, or alcohol during pregnancy
- Having a contraindication to exercise
Recruiting US locations
Human Performance Laboratory (HPL) at the University of Central Arkansas
Conway, AR 72035
Site contact: Brittany R Tucker, PhD · 484-802-6852 · rallman@uca.edu
Study contacts (from the official record)
- Brittany R Tucker, PhD · 484-802-6852 · rallman@uca.edu
- Jamie Baum, PhD · 479-601-2499 · baum@uark.edu
Similar studies in Arkansas
All diabetes studies in Arkansas →- RecruitingPhase 3
A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
Boehringer Ingelheim
- Location
- Little Rock, AR + 56 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
Regeneron Pharmaceuticals
- Location
- Little Rock, AR + 55 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 3
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
Eli Lilly and Company
- Location
- Little Rock, AR + 39 other US sites
- Eligibility basics
- Ages 10–17
- RecruitingPhase 3
Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy
Vertex Pharmaceuticals Incorporated
- Location
- Little Rock, AR + 69 other US sites
- Eligibility basics
- Ages 18–80